Back to Trades
Sell4
VERTEX PHARMACEUTICALS INC / MA
VRTX
Total Value
$583.9K
Net $301.5K sold
Sales
$301.5K
1 transaction
Company Information
- Company Name
- VERTEX PHARMACEUTICALS INC / MA
- Ticker Symbol
- VRTX
- CIK
- 0000875320
Insider Information
- Name
- Bunnage Mark E.
- Role
- EVP, Chief Scientific Officer
- Location
- BOSTON, MA
Officer
Filing Details
- Filing Date
- Feb 26, 2026
- Transaction Date
- Feb 24, 2026
- Accession Number
- 0000875320-26-000112
- Form Type
- 4
- Net Trading Amount
- -$301.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | Common Stock | 582 | $485.11 | Tax Withholding | $282.3K |
| Feb 25, 2026 | Common Stock | 620 | $486.35 | Sale | $301.5K |
Footnotes
- (F1)Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025.